These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7038504)

  • 1. Reversal of natural killer defect in a patient with Chédiak-Higashi syndrome after bone-marrow transplantation.
    Virelizier JL; Lagrue A; Durandy A; Arenzana F; Oury C; Griscelli C; Reinert P
    N Engl J Med; 1982 Apr; 306(17):1055-6. PubMed ID: 7038504
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cell activity in a patient with Chédiak-Higashi syndrome submitted to bone marrow transplantation.
    Diamond HR; Souza MH; Silva ML; Tabak DG; Ferman S; M-Silva VM; de La Rocque L; Rumjanek VM
    Pediatr Hematol Oncol; 1995; 12(4):399-402. PubMed ID: 7577393
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplantation in a patient with Chédiak-Higashi Syndrome.
    Griscelli C; Virelizier JL
    Birth Defects Orig Artic Ser; 1983; 19(3):333-4. PubMed ID: 6360244
    [No Abstract]   [Full Text] [Related]  

  • 4. Chediak-Higashi syndrome: reversal of increased susceptibility to infection by bone marrow transplantation.
    Kazmierowski JA; Elin RJ; Reynolds HY; Durbin WA; Wolff SM
    Blood; 1976 Apr; 47(4):555-9. PubMed ID: 769863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases.
    Haddad E; Le Deist F; Blanche S; Benkerrou M; Rohrlich P; Vilmer E; Griscelli C; Fischer A
    Blood; 1995 Jun; 85(11):3328-33. PubMed ID: 7756666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chediak-Higashi syndrome natural killer cells: a protein kinase C defective activation/regulation defect?
    Merino F; Esparza B; Sabino E
    Eur J Pediatr; 1996 Mar; 155(3):254. PubMed ID: 8929738
    [No Abstract]   [Full Text] [Related]  

  • 7. Chédiak-Higashi syndrome: hematopoietic chimerism corrects genetic defect.
    Trigg ME; Schugar R
    Bone Marrow Transplant; 2001 Jun; 27(11):1211-3. PubMed ID: 11551033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a murine model (beige) for a natural killer cell immunodeficiency in the Chediak-Higashi syndrome of man.
    Roder JC
    Prog Clin Biol Res; 1982; 94():315-25. PubMed ID: 7122620
    [No Abstract]   [Full Text] [Related]  

  • 10. [The accelerated phase of Chediak-Higashi syndrome].
    Bejaoui M; Veber F; Girault D; Gaud C; Blanche S; Griscelli C; Fischer A
    Arch Fr Pediatr; 1989 Dec; 46(10):733-6. PubMed ID: 2697195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
    Katz P; Zaytoun AM; Lee JH; Fauci AS
    J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
    [No Abstract]   [Full Text] [Related]  

  • 12. T gamma cells in Chediak-Higashi syndrome.
    van de Griend RJ; Astaldi A; de Bruin HG; Weening RS
    N Engl J Med; 1982 Jun; 306(22):1368-9. PubMed ID: 6978462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chediak-Higashi disease: a new case treated by bone marrow allograft].
    Demory JL; Senlecq-Tack S; Decoster A; Duhamel M; Spyckerelle C; Vittu G; Cousin J; Fischer A; Griscelli C
    Ann Pediatr (Paris); 1989 Jun; 36(6):387-9. PubMed ID: 2667428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered lectin-mediated cytotoxicity in Chédiak-Higashi syndrome patients.
    Merino F; Rodríguez F; Biondo-Bracho M; Amesty C; Ramírez-Duque P
    Clin Immunol Immunopathol; 1984 Nov; 33(2):139-43. PubMed ID: 6333304
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chediak-Higashi syndrome in an adult female].
    Utsunomiya A; Saito T; Hanada S; Tin E; Oshige T; Hashimoto S; Hamaguchi Y; Ueno T
    Rinsho Ketsueki; 1988 Sep; 29(9):1422-6. PubMed ID: 3216514
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperpigmentation in Chediak-Higashi syndrome.
    Al-Khenaizan S
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S244-6. PubMed ID: 14576641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chediak-Higashi syndrome: clinical, hematologic, and immunologic improvement after splenectomy.
    Harfi HA; Malik SA
    Ann Allergy; 1992 Aug; 69(2):147-50. PubMed ID: 1510287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects of immune interferon secretion and natural killer activity in patients with immunological disorders.
    Virelizier JL; Lipinski M; Tursz T; Griscelli C
    Lancet; 1979 Sep; 2(8144):696-7. PubMed ID: 90787
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
    Tardieu M; Lacroix C; Neven B; Bordigoni P; de Saint Basile G; Blanche S; Fischer A
    Blood; 2005 Jul; 106(1):40-2. PubMed ID: 15790783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid ultrastructural detection of success or failure after bone marrow transplantation in the Chediak-Higashi syndrome.
    White JG; Hess RA; Gahl WA; Introne W
    Platelets; 2013; 24(1):71-4. PubMed ID: 22738378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.